Chronic Fatigue in EDS
Peter C. Rowe, MD
Sunshine Natural Wellbeing Foundation Professor of Chronic Fatigue and Related Disorders
Department of Pediatrics Johns Hopkins University School of Medicine
EDNF Learning Conference
July 22-23, 2011
Chronic Fatigue in EDS
• Chronic fatigue and CFS definitions• Lessons from CFS• CF and CFS in EDS• Insights of treating chronic fatigue
– Treating orthostatic intolerance– Non IgE-mediated food protein allergies – The paradox of movement restrictions in EDS– Ovarian vein varices/pelvic congestion
Fatigue
An overwhelming sustained sense of exhaustion and decreased capacity for physical and mental work.
Piper BF. 1989
Fatigue Definitions
• Prolonged fatigue: fatigue lasting 1 – 6 mo.• Chronic fatigue: fatigue lasting > 6 mo.• Chronic fatigue syndrome: new onset fatigue,
lasting > 6 mo., unrelieved by rest and 4/8 somatic symptoms
From MJA 2002; 176:S17-S55
Symptom Criteria For CFS4 of 8 needed for diagnosis Fukuda et al. Ann Int Med 1994;121:953-9
• unrefreshing sleep • postexertional malaise lasting > 24 hours• self reported impairment in short-term memory
or concentration • sore throat • tender cervical or axillary glands • muscle pain • multijoint pain without swelling • headaches of a new type, pattern, severity
CFS Clinical Evaluation Fukuda et al. Ann Int Med 1994;121:953-9
• History, physical, mental status exam• Screening labs:
– CBC, ESR/CRP, Chemistries, TSH– Urinalysis– Iron studies, vitamin B12, celiac screening,
and, in endemic areas, labs for Lyme and tick-borne infections
• Other labs as clinically indicated
Chronic Fatigue in EDS
• Chronic fatigue and CFS definitions• Lessons from CFS• CF and CFS in EDS• Insights of treating chronic fatigue
– Treating orthostatic intolerance– Non IgE-mediated food protein allergies – The paradox of movement restrictions in EDS– Ovarian vein varices/pelvic congestion
CFS Epidemiology
General Affects previously active individuals
Heterogeneous precipitating & perpetuating factors
Shift in perception of CFS: No longer considered a single
disease More likely a convergence of co- morbid pathophysiologic
influences
CFS Epidemiology
Prevalence 4/1,000 adults; 1/1,000 adolescentsAge Uncommon under 10 years
Peak prevalence 40-49 yearsGender 2-4 F : 1 MSES Affects all groupsGenetics Twice as common in MZ as DZ
twinsAssociated with EDSAssociated with joint hypermobility
Research Findings
• Acute illness appears to precipitate symptoms in up to 2/3, but evidence of active infection not detected in chronic state (enteroviral infection, Lyme may be exceptions)
• Severity of acute infection, not psychological factors, is key determinant of who develops CFS after acute illness
• XMRV not an etiologic agent• Immune abnormalities inconsistent & mild• Post-exercise increases in cytokines and genes
involved with adrenergic function and pain
Light AR et al. J Pain 2009;10:1099
Research Findings
• Orthostatic stress and exercise consistently provoke CFS symptoms
• All pediatric and most adult studies confirm higher prevalence of orthostatic intolerance
• Open treatment of OI leads to improvement in function
• CBT and graded exercise provide modest improvement in function but not cure
• Low rates of spontaneous improvement for those with > 3 yrs of symptoms
Orthostatic Intolerance
The term “orthostatic intolerance” refers to a group of clinical conditions in which symptoms worsen with quiet upright posture and are ameliorated (although not necessarily abolished) by recumbency.
Modified from: Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol
2009;20:352-8.
Low PA
Rowell LB
Human Cardiovascular Control, 1993
Symptoms Of Orthostatic Intolerance
Lightheadedness DyspneaSyncope Chest Discomfort Diminished concentration PalpitationsHeadache TremulousnessBlurred vision AnxietyFatigue NauseaExercise intolerance Nocturia
↑ pooling,↓ vasoconstriction ↓ intra-vascular volume
↑ sympatho-adrenal response
NMH POTS
NE/EpiNE/Epi
Orthostatic stress
Response To Upright Tilt: CFS
Abnormal Normal
Stage of tilt 1 2 3
CFS 16 3 3 1CONTROL 0 1 3 10
OR for abnormal tilt in those with CFS: 55 (95% CI, 5.4 - 557)
Bou-Holaigah, Rowe, Kan, Calkins. JAMA 1995;274:961-7.
JAMA 1995;274:961-7.
Response to open treatment of orthostatic intolerance
CFS And Psychiatry
• Many CFS patients have anxiety or depression, but prevalence estimates vary widely depending on the case definition used
• Severity usually mild, anhedonia uncommon• Post-exertional malaise more common in CFS• Treating depression and anxiety can improve
these symptoms, but usually does not cure CFS
White PD et al. PACE trial. Lancet 2011
12 wks 24 wks 52 wks
Chronic Fatigue in EDS
• Chronic fatigue and CFS definitions• Lessons from CFS• CF and CFS in EDS• Insights of treating chronic fatigue
– Treating orthostatic intolerance– Non IgE-mediated food protein allergies – The paradox of movement restrictions in EDS– Ovarian vein varices/pelvic congestion
Classical type EDS:“Fatigue is a frequent complaint.”
Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup R. Ehlers Danlos Syndromes: Revised nosology, Villefranche, 1997
Orthostatic Intolerance
EDS/Joint hypermobilityCFS
Orthostatic Intolerance And Chronic Fatigue Syndrome Associated With EDS
Among approximately 100 adolescents seen in the CFS clinic at JHH over a 1 year period, we identified 12 subjects with EDS
6 classical-type, 6 hypermobile-type EDS
11 female; median age 15 yrs (9-21)
NMH in 9/12, POTS in 10/12 Rowe PC, Barron DF, Calkins H, Maumanee IH, Tong PY, Geraghty
MT. J Pediatr 1999;135:494-9
Joint Hypermobility In Children With CFS
Study question: do children with CFS have a higher prevalence of joint hypermobility?
Beighton scores obtained in 58 new & 58 established CFS patients, and in 58 controls
Median Beighton scores higher in CFS (4 vs. 1)
Beighton score > 4 higher in CFS (60% vs. 24%)
Barron DF, Cohen BA, Geraghty MT, Violand R, Rowe PC. J Pediatr 2002;141:421-5
Beighton Joint Hypermobility Scores in 58Adolescents With CFS And 58 Healthy Controls
0
5
10
15
20
25
30
35
0 - 1 2 - 3 4 - 5 6 - 7 8 - 9
HealthyCFS
Beighton scores
#
Barron, Geraghty, Cohen, Violand, Rowe. J Pediatr 2002;141:421-5
How might joint hypermobility be associated with OI and CFS?
Working hypothesis:
Connective tissue laxity in blood vessels allows increased vascular compliance, promotes excessive pooling during upright posture, leading to diminished blood return to the heart, and thus to OI symptoms
Rowe PC, et al. J Pediatr 1999;135:494-9
Fatigue is a frequent and clinically relevant problem in EDS
(Voermans NC, et al. Semin Arth Rheum 2010; 40:267-74)
• 273 patients with EDS • 77% severe fatigue• 57% reported fatigue as 1 of their 3 most important
symptoms• Severe fatigue was more common in hypermobile
than classical EDS (84% vs. 69%; P=.032)• Fatigue had a greater impact on daily function than
did pain
Fatigue is a frequent and clinically relevant problem in EDS
(Voermans NC, et al. Semin Arth Rheum 2010; 40:267-74)
On the basis of their results, the authors speculate about a potential treatment:
“A cognitive behavioral intervention focusing on pain, sleep disturbances, the reaction of others to the symptoms, and self-efficacy concerning fatigue could help reduce fatigue and fatigue-related disabilities.”
Chronic Fatigue in EDS
• Chronic fatigue and CFS definitions• Lessons from CFS• CF and CFS in EDS• Insights of treating chronic fatigue
– Treating orthostatic intolerance– Non IgE-mediated food protein allergies – The paradox of movement restrictions in EDS– Ovarian vein varices/pelvic congestion
Anxiety
Inhalant allergies/asthma
Infection
Pelvic vein incompetence
EDS/JHSDepression
Chiari type I or c-spine
stenosis
Chronic fatigue syndrome
Migraines
Orthostatic intolerance
Food allergies
Movement restrictions
Treating chronic fatigue
1. Careful history and physical exam, supplemented by questionnaires, to develop working hypotheses about the dominant influences on fatigue
2. Begin working on graded increases in activity, physical therapy if needed
3. Begin treating the dominant influences on symptoms
4. Reassess and repeat steps 1-3
16 year old with fatigue: visit 1
Gastroesophageal reflux and colic in 1st year of lifeOnset of fatigue and daily lightheadedness at age 13Develops syncope X 3; MigrainesGI: early satiety, reflux, abdo pain, aphthous ulcersO/E: Beighton score 7/9, blue sclerae, easy eyelid
eversion, pes planus, papyraceous scar of L knee.Limitations on physical therapy ROM despite joint hypermobilityBeck Depression Inventory: dysthymia
Visit 1 hypothesis formulation
Imp: EDSOI (already on Florinef)Milk protein intoleranceMigraines Movement restrictionsDsythymia
Plan: Milk-free diet institutedLow dose cyproheptadine
Anxiety
Inhalant allergies/asthma
Infection
Pelvic vein incompetence
EDS/JHSDepression
Chiari type I or c-spine
stenosis
Chronic fatigue syndrome
Migraines
Orthostatic intolerance
Food allergies
Movement restrictions
16 year old with fatigue
Visit 2: GI symptoms resolved unless he gets inadvertent milk re-exposure; mood more of the problem
Plan: Low dose Lexapro for mood
Visit 3: Mood improved, but still has some orthostatic exacerbation of migraines; still tight on PT exam
Plan: Add midodrine for OI; begin PT
16 year old with fatigue
Visit 4: Migraine resolved; better ROMTrial off Lexapro: mood & HA worse,
but able to drop to 2.5 mg daily “The more I do, the more I can do”
Plan: Continue PT
Visit 5: Good year, on HS soccer and tennis teams No syncope; migraines only if he does not maintain good hydration
Plan: No changes.
Non-IgE mediated food allergy :3 cardinal features
1. Recurrent vomiting or GER 2. Recurrent epigastric or abdominal pain 3. Food refusal, picky eating, early satiety
Other: aphthous ulcers, unexplainedfevers, diarrhea or constipation, headache,myalgias, fatigue, asthma
Kelly KJ et al. Gastroenterology 1995;109:1503-12
Non-IgE mediated food allergy
• Reaction to suspected food usually delayed 2-6 hrs• IgE level, prick skin tests, RAST tests often neg. • Eosinophilic esophagitis only the tip of the iceberg• Treated with strict avoidance of offending food
proteins (milk > soy > egg > wheat); amino acid formulas occasionally needed in infants
• Diagnosis supported by clinical response to diet, recurrence of symptoms 2-6 hours after inadvertent dietary challenge, confirmed by DBPCOFC
Improvements in esophageal eosinophils after amino acid formula diet
Kelly KJ et al. Gastroenterology 1995;109:1503-12
Chronic Fatigue in EDS
• Chronic fatigue and CFS definitions• Lessons from CFS• CF and CFS in EDS• Insights of treating chronic fatigue
– Treating orthostatic intolerance– Non IgE-mediated food protein allergies – The paradox of movement restrictions in EDS– Ovarian vein varices/pelvic congestion
Paradox of movement restrictions in EDS
• Increased prevalence of postural abnormalities and movement restrictions among those with CFS
• CFS symptoms can be reproduced by selectively placing tension on the neural tissues
• Focal movement restrictions are common even in those with generalized joint hypermobility/EDS
• Improvement in ROM, orthostatic tolerance, and exercise tolerance can follow manual therapy
Abnormal postures
Restricted Straight Leg Raise
Healthy CFS
Symptom Changes with SLR over 12 minutes in Adolescent with CFS
0123456789
10
0 10 20 30 40 50 60 0
FatigueLHCog FogVis Blur
Degrees of SLR
Severity
How Might Movement Restrictions Be Associated With CFS?
• Pathophysiology of symptoms with neural elongation strain awaits clarification, but we hypothesize that it contributes to central sensitivity
• Informally, improvement in symptoms, ROM, orthostatic tolerance, and exercise tolerance appears to follow manual therapy designed to reduce adverse neural tension and improve movement restrictions
Manual Therapy Principles
• Use of the hands to restore full, symptom-free mobility within the neuromuscular and articular systems
• Goal of treatment is the same as that of exercise-based PT, but manual practitioners treat movement restrictions first before advancing the patient to strenuous activity
Manual Techniques
• Slow non-thrust manipulations– Sustained stretching– Passive oscillatory movements (neural mobs)– Muscle energy techniques
• Gentle indirect techniques– Myofascial release– Strain and counter-strain– Cranio-sacral therapy
Chronic Fatigue in EDS
• Chronic fatigue and CFS definitions• Lessons from CFS• CF and CFS in EDS• Insights of treating chronic fatigue
– Treating orthostatic intolerance– Non IgE-mediated food protein allergies – The paradox of movement restrictions in EDS– Ovarian vein varices/pelvic congestion
16 yr old with EDS, CFS, OI, and 2 yr history of disabling lower back and pelvic pain
• Pain worse as the day goes on• Pelvic pain present with urination, when back pain
present, with menses• Unable to tolerate sitting in school• Lower abdominal distention as the day goes on• X-rays, scans, MRI of lumbar spine negative• Unresponsive to OCPs, NSAIDs, TENS unit,
neurontin, TCA, lumbar support garments, PT, inpatient evaluation
Left ovarian vein venogram
Catheter in distal L ovarian vein plexus; arrows denote reflux of contrast into internal iliac veins
Pre Post
Pelvic Congestion SyndromeVenbrux AC, Lambert DL. Curr Opin Ob Gyn 1999; 11:395
• Pelvic heaviness or pain with long periods of standing
• Worse at end of the day, during menses• Associated symptoms: fatigue,
dyspareunia, bladder urgency• Strong association with varicose ovarian
veins • 89% have > 80% relief after
embolization of ovarian vein varicosities
CFS and ovarian varices: JHH experience
• 24 consecutive females with chronic pelvic pain unresponsive to NSAIDs, OCPs, & no other cause identified on Hx, PE, imaging
• median age 19, range 16-54• 16 were < 21 yrs; all but 4 nulliparous• Median duration of pelvic pain 4 yrs (1-15)• All had orthostatic intolerance• 14/24 with EDS
Kaushik S, et al. JHH 2003
16 yr old with EDS, CFS, OI, and 2 yr history of disabling lower back and pelvic pain
Outcome
• Improved symptoms following ovarian and internal iliac embolization
• Able to attend school daily• Able to wean midodrine for OI• No further syncope• Wellness score > 90/100
1. What are the risk factors for fatigue in JHS/EDS? 2. What is the prevalence of OI in EDS patients?3. What is the prevalence of CFS or fibromyalgia
symptoms in JHS/EDS? 4. Do therapies directed at OI & related co-
morbidities in JHS and EDS improve QOL?
Opportunities for Research
Treatment of orthostatic intolerance
Webinar from September 2010 available on the CFIDS Association of America web site:
www.cfids.org
Low High
Common
Uncommon
Chronic Fatigue
Tolerance of orthostatic stress
Relationship of orthostatic intolerance to chronic fatigue
Low High
Common
Uncommon
Chronic Fatigue
Tolerance of orthostatic stress
Can we move fatigue levels from A to B by treating orthostatic intolerance?
A
B
Step 1: Non-pharmacologic measures
Where possible, avoid factors that precipitate symptoms
Precipitating Factors For OI• Increased pooling/decreased volume
Prolonged sitting or standing Warm environment Sodium depletion Prolonged bed rest
Varicose veins High carbohydrate mealsDiuretics, vasodilators, alpha-blockersAlcohol
Precipitating Factors For OI
• Increased catecholamines StressExercisePainHypoglycemiaAlbuterolEpinephrine
Step 1: Non-pharmacologic measures
Compression garments– Support hose
(waist high > thigh high > knee high)– Body shaper garments– Abdominal binders
Step 1: Non-pharmacologic measures
Use postural counter-measures• standing with legs crossed• squatting• knee-chest sitting• leaning forward sitting• elevate knees when sitting (foot rest)• clench fists when standing up[Use the muscles as a pump]
Step 1: Non-pharmacologic measures
Fluids: Minimally 2 L per dayDrink at least every 2 hours Need access to fluids at schoolAvoid sleeping > 12 hrs/day
Salt: Increase according to tasteSupplement with salt tablets
Step 1: Non-pharmacologic measures
ExerciseAvoid excessive bed rest/sleepingFor most impaired, start exercise slowly, increase graduallyRecumbent exercise may help at outset Manual forms of PT may be a bridge to better tolerance of exercise“Inactivity is the enemy”[Similar to principles of CBT regarding graded increases in activity]
Treatment Of Orthostatic Intolerance
• Step 1: non pharmacologic measures
• Step 2: treating contributory conditions
• Step 3: medications– Monotherapy– Rational polytherapy
Anxiety
Inhalant allergies/asthma
Infection
Menstrual pain; ovarian
varices
EDS/JHSDepression
Chiari type I or c-spine
stenosis
Chronic fatigue syndrome
Migraines
Orthostatic intolerance
Food allergies
Movement restrictions
Treatment Of Orthostatic Intolerance
• Step 1: non pharmacologic measures
• Step 2: treating contributory conditions
• Step 3: medications– Monotherapy– Rational polytherapy
Therapy For Orthostatic Intolerance
• blood volumeSodium (PO & occasionally IV), fludrocortisone, clonidine, OCPs
• catecholamine release or effect -blockers, disopyramide, SSRIs, ACE inh. • Vasoconstriction Midodrine, dexedrine, methylphenidate, SSRIs,
SNRIs, aescin (horse chestnut seed extract)• Misc
pyridostigmine bromide
↑ pooling,↓ vasoconstriction ↓ intra-vascular volume
↑ sympatho-adrenal response
NMH POTS
↑ NE/Epi↓ NE/Epi
Orthostatic stress
Vasoconstrictors Volume expanders
Reduce catecholamine release/effect
How to select initial therapy?
Algorithm vs. individualized approaches
Johnson JN, et al. Pediatr Neurology 2010; 42:77-85
Algorithm approach for POTS from Mayo Clinic investigators
Individualized approach
• SBP < 110: fludrocortisone, midodrine• Increased HR at baseline or when upright: -blocker
• Based on other clinical cluesIncreased salt appetite: fludrocortisone HA: -blocker Dysmenorrhea/worse fatigue with menses: OCP, DepoAnxiety/low mood: SSRI, SNRIMyalgias prominent: SNRIFH of ADHD: stimulantHypermobility: stimulant, midodrine
Modified from Bloomfield, Am J Cardiol 1999;84:33Q-39Q
Management of orthostatic intolerance
• requires careful attention by the patient and the practitioner to the factors that provoke symptoms
• requires a willingness to try several medications before a good fit is achieved
• requires a realization that meds often can treat symptoms but do not necessarily cure OI
• management of OI is one part of a comprehensive program of care for patients with other disorders (GI dysautonomia, CFS)